Breeding cannabis strains with more desired cannabinoids could advance medicinal treatments

Access to medicinal cannabis may be subject to specific requirements in each state and territory. Ultimately, CannaPacific hopes that producing cultivars with the desired cannabinoid content will “support the development of new medicinal cannabis treatments and novel cannabinoid product formulations.” / Photo: Christopher Furlong/Getty Images Ultimately, CannaPacific hopes that producing cultivars with the desired cannabinoid content will “support the development of new medicinal cannabis treatments and novel cannabinoid product formulations,” says Tim Bowser, chief scientific officer for the company, which is licenced by the Australian government to cultivate and research medicinal cannabis. Move over marijuana, these six plants contain cannabinoids, too Hidden gems of the cannabis plant: Lesser-known cannabinoids and their medical benefits Patients don’t consider doctors to be a good source of cannabis info Minor cannabinoids, some of which have been shown to have medicinal benefits or promise, are present in strains. Focusing on novel traits of cannabis plants, a partnership among CannaPacific, Xing Technologies and Newcastle University, seeks to develop “one of the most advanced medical cannabis genomic breeding programs in the world,” notes a statement from CannaPacific. Subscribe to the Cannabis Post newsletter for weekly insights into the industry, what insiders will be talking about and content from across the Postmedia Network.